# Mariana Mihalusova

> Mariana Mihalusova is a seed investor at Venrock backing Biotechnology and Therapeutics. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Venrock](https://shizune.co/investors/profile/venrock)
- Location: San Francisco Bay Area, United States
- Total investments: 3
- Last investment: Jan 2025
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/mihalusova

Mariana Mihalusova is a Vice President at Venrock.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 100% |
| Therapeutics | 2 | 67% |
| Biopharma | 1 | 33% |
| Life Science | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Series A | 1 | 33% |
| Series C | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 2 | 67% |
| Switzerland | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| K2 Therapeutics | K2 Therapeutics creates advanced antibody-based therapies focused on difficult multi-pass membrane targets to address unmet disease needs. |  | Seed | Jan 01, 2025 |  |
| Bright Peak Therapeutics | Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases. At Bright Peak, they are creating innovative cytokine therapeutics that are uniquely engineered to precisely control and expand desired biological properties. | $90M | Series C | Jun 11, 2024 |  |
| MBrace Therapeutics | MBrace Therapeutics is a privately held biopharmaceutical business dedicated to improving cancer patients' quality of life by developing antibody-drug conjugates (ADCs) against novel oncology targets. | $25M | Series A | Jan 01, 2021 |  |

3 of 3 investments shown.

## Co-investors
- [RA Capital Management](https://shizune.co/investors/profile/ra-capital-management) — VC Fund, 2 deals together
- [Versant Ventures](https://shizune.co/investors/profile/versant-ventures) — VC Fund, 2 deals together
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund, 1 deal together
- [Alta Partners](https://shizune.co/investors/profile/alta-partners) — VC Fund, 1 deal together
- [Fidelity](https://shizune.co/investors/profile/fidelity-investments) — VC Fund, 1 deal together
- [Invus](https://shizune.co/investors/profile/invus) — VC Fund, 1 deal together

## About Venrock

VC Fund · Palo Alto, United States

Venrock continues a tradition of partnering with entrepreneurs to establish successful, enduring companies. With a primary focus on technology and healthcare, portfolio companies have included Apple Computer, Athenahealth, Centocor, Check Point Software, DoubleClick, Endeca, Gilead Sciences, Idec Pharma, Imperva, Illumina, Intel, Nest, SlideShare,and Tudou.

5 contacts available at Venrock.

| Name | Title | Profile |
| --- | --- | --- |
| Andrew Gottesdiener | Partner | https://shizune.co/investors/profile/andrew-gottesdiener-91c0 |
| Anthony Evnin | Partner Emeritus | https://shizune.co/investors/profile/anthony-evnin |
| Bryan Roberts | Partner | https://shizune.co/investors/profile/bryan-e-roberts |
| Mariana Mihalusova | Vice President | https://shizune.co/investors/profile/mariana-mihalusova-65b2 |
| Mike Tyrrell | General Partner | https://shizune.co/investors/profile/mike-tyrrell |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Mariana Mihalusova invest in?

Mariana Mihalusova invests primarily in Biotechnology, Therapeutics and Biopharma startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Mariana Mihalusova last invest?

The most recent investment recorded for Mariana Mihalusova closed in Jan 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co